CytomX Therapeutics
CTMX
HK$19.47
Share price
5.08%
Change (1 day)
88.87%
Change (1 year)
Categories
CytomX Therapeutics (CTMX) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : HK$0.57 Billion
According to CytomX Therapeutics 's latest financial reports the company's total liabilities are HK$0.57 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
CytomX Therapeutics - Total liabilities on balance sheet (from 2014 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | HK$0.93 B | -51.75% |
| 2023-12-31 | HK$1.94 B | -28.13% |
| 2022-12-31 | HK$2.70 B | 2.2% |
| 2021-12-31 | HK$2.65 B | -6.71% |
| 2020-12-31 | HK$2.84 B | 25.7% |
| 2019-12-31 | HK$2.25 B | -11.54% |
| 2018-12-31 | HK$2.55 B | -0.24% |
| 2017-12-31 | HK$2.56 B | 173.7% |
| 2016-12-31 | HK$0.93 B | 69.66% |
| 2015-12-31 | HK$0.55 B | -53.11% |
| 2014-12-31 | HK$1.17 B | 159.39% |
| 2013-12-31 | HK$0.45 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | HK$0.18 B | -68.52% | 🇺🇸 USA |